Wenhui Wei (former graduate student in the Smrcka Lab) recently had a publication come out in AHA Journals.

Gisselle Sanchez, Ph.D. (former Ph.D. student in the Smrcka and Jutkiewicz Labs) recently had publication come out in ASPET Molecular Pharmacology.

Youth with heart disease enrolled in unique program that teaches resilience and builds connections with their peers

Researchers uncovered nine elements that have significant effects on a whether a patient may develop pneumonia, with nearly 20% of patients moving into a higher risk category based on what occurred during or following the surgery.

2024 ASPET Meeting Awards: Congratulations, Jacob, Gwen, and Ben!

Congratulations to Liz Jaeckel on successfully defending her dissertation

Congratulations to Dr. Paul Jenkins on his promotion to Associate Professor with Tenure!

Congratulations to Dr. Greg Tall on his promotion to Full Professor with Tenure!

Dr. Colin Greineder is promoted to Associate Professor with tenure in Emergency Medicine and to Associate Professor without tenure in Pharmacology.

Nearly 200 Medical School faculty members earned promotions in the 2024 cycle. Their new appointments were approved May 16 by the U-M Board of regents and take effect Sept. 1, 2024.

The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.

A team of researchers have spent the past eight years looking at better ways to transport organs for donation, specifically hearts, to improve the number of organs that can be used for transplants. They found that using a modified normothermic perfusion system heart preservation was feasible for up to 24 hours.

Mike Holinstat, Ph.D., recently co-authored an article, "An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis", that was posted in CELL.

In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.